GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eidos Therapeutics Inc (FRA:6MX) » Definitions » Cash From Other Investing Activities

Eidos Therapeutics (FRA:6MX) Cash From Other Investing Activities : €0.00 Mil (TTM As of Sep. 2020)


View and export this data going back to 2018. Start your Free Trial

What is Eidos Therapeutics Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Eidos Therapeutics's cash from other investing activities for the three months ended in Sep. 2020 was €0.00 Mil. It means Eidos Therapeutics received €0.00 Mil from other investing activities. Eidos Therapeutics's cash from other investing activities for the trailing twelve months (TTM) ended in Sep. 2020 was €0.00 Mil.

Eidos Therapeutics Cash From Other Investing Activities Historical Data

The historical data trend for Eidos Therapeutics's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eidos Therapeutics Cash From Other Investing Activities Chart

Eidos Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19
Cash From Other Investing Activities
- - - -

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Eidos Therapeutics Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eidos Therapeutics Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Eidos Therapeutics's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eidos Therapeutics (FRA:6MX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eidos Therapeutics Inc (FRA:6MX) » Definitions » Cash From Other Investing Activities
Comparable Companies
CORT ZYME ARVN XNCR LGND IMVT MDGL TBPH SWTX ZGNX OCSE:NOVO B ASX:CSL VRTX REGN XKRX:207940 SGEN MRNA ALXN XKRX:068270 INCY
Traded in Other Exchanges
N/A
Address
101 Montgomery Street, Suite 2000, San Francisco, CA, USA, 94104
Website
https://www.eidostx.com
Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins. The company's product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR.

Eidos Therapeutics (FRA:6MX) Headlines

No Headlines